Fritextsökning
Innehållstyper
-
SBU: Planerade kejsarsnitt ger högre risk för både kvinnan och barnet
medicinsk och social utvärdering.
-
Forskare undersökte syrapumpshämmare med datorsimuleringar – gör koppling till demens
Forskare från Karolinska institutet har i en preklinisk studie sett en mekanism som de anser pekar på att långvarig användning av syradämpande läkemedel kan bid...
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Över 1 200 fick gendiagnos: "Kan vara livsavgörande"
Över 1 200 personer har fått en diagnos på sällsynt sjukdom genom den storskaliga helgenomsekvensering som skett i samarbete mellan sjukvård och akademi i Regio...
-
Årets opinionsartiklar
Missa inte de opinionsartiklar som har blivit mest lästa i Life Science Sweden.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Här är hela listan med de svenska ERC-miljonerna
Totalt har 236 forskare fått pengar från det europeiska forskningsrådet ERC. Tolv av dem kommer att arbeta med sina projekt i Sverige.
-
Sobi och Sanofi får genombrottsstatus för behandling mot blödarsjuka
En behandling mot hemofili A, utvecklad av svenska Sobi tillsammans med Sanofi, har tilldelats genombrottsstatus i USA. Det är den första faktor VIII-behandling...
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Hopp om att remdesivir ska ha effekt på coronaviruset
I väntan på coronavaccin ser många remdesivir som en av få läkemedel som har en rimlig chans att hjälpa patienter med coronavirus. Nu har Gilead science ökat pr...
-
Happy exhibitors!
There were fewer vistors this year but most exhibitors are content.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Rapid and thorough homogenization of samples
MP Biomedicals presents the Fasprep-24 instrument, a new high-throughput model of the earlier Bio 101 Systems Fastprep homogenizer.
-
Ny kommunikationschef på Hansa
Katja Margell är ny Head of Corporate Communications på Hansa Biopharma.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Vitamin D is mental health aid
Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
BREAKING